GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹94 Cr | ₹116 Cr |
| Adjustment | ₹44 Cr | ₹34 Cr |
| Changes In working Capital | ₹7.44 Cr | ₹-130 Cr |
| Cash Flow after changes in Working Capital | ₹145 Cr | ₹20 Cr |
| Cash Flow from Operating Activities | ₹123 Cr | ₹-7.46 Cr |
| Cash Flow from Investing Activities | ₹-71 Cr | ₹-102 Cr |
| Cash Flow from Financing Activities | ₹-37 Cr | ₹82 Cr |
| Net Cash Inflow / Outflow | ₹15 Cr | ₹-27 Cr |
| Opening Cash & Cash Equivalents | ₹1.14 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹16 Cr | ₹1.14 Cr |
Compare Cashflow Statement of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,860.6 Cr | -4% | 1.3% | -21.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -4% |
1.3% |
-21.2% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses